Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study. - Wikidata - awgldk - TriplyDB

Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study.

Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study.

http://www.wikidata.org/entity/Q34559981

about

Dipeptidyl Peptidase 4 Inhibitors and the Risk of Cardiovascular Disease in Patients with Type 2 Diabetes: A Tale of Three Studies Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke Assessing the efficacy and safety of combined DPP-4 inhibitor and insulin treatment in patients with type 2 diabetes: a meta-analysis SAVOR-TIMI to SUSTAIN-6: a critical comparison of cardiovascular outcome trials of antidiabetic drugs.Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials.Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.The effect of sitagliptin on cardiovascular risk profile in Korean patients with type 2 diabetes mellitus: a retrospective cohort study Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study.Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes.Managing comorbidities in patients with chronic heart failure: first, do no harm.Dipeptidyl peptidase-4 inhibitor use in patients with type 2 diabetes and cardiovascular disease or risk factors.No increased risk of cardiovascular events in older adults initiating dipeptidyl peptidase-4 inhibitors vs therapeutic alternatives.Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.Adverse effects of incretin-based therapies on major cardiovascular and arrhythmia events: meta-analysis of randomized trials.Identification of predictors of response to basal insulin and DPP4 inhibitors in patients with type 2 diabetes failing to other therapies.Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis.Comparative cardiovascular risks of dipeptidyl peptidase 4 inhibitors with other second- and third-line antidiabetic drugs in patients with type 2 diabetes.

P2860

Q26777177-C0E0A91A-C125-4105-838C-A4613B5C9417 Q26861493-B714E5DA-0630-4903-8C8F-2CE36EC279EC Q28075335-6C3AA0F6-CEDE-4BEE-BB79-70DCA2A4F0BF Q30238791-36859DFC-A66C-43B9-95E8-4F46454E82DE Q30248634-698F89F4-41F6-47D8-B617-8E30E55552E7 Q36639308-E4FA4095-41F4-44E8-A389-6210F503DFF9 Q36710078-943CC3BB-8494-4E67-9854-97C59321F44D Q37145172-E81B51D3-2964-4C30-8431-6EC3A11BBC40 Q37527438-5E8729C5-3D31-47A0-89A9-BBEF1E32D1C7 Q38335751-2E91765A-B306-4E2E-98F6-203A85E7DED0 Q38402807-15F164E9-EC75-459D-BA71-3FEE7811F57E Q38599145-D0355847-CA6D-48EB-9643-5C809A9A2D2A Q38962521-DA2C4192-14DC-4981-89F8-303520437362 Q39350860-20AFE7A4-D2CD-4215-8108-5F6BF56CB4FE Q39870068-AEA5D571-FADE-4C3A-8E45-75698ACD2B7C Q41168197-BC84C967-147D-40F4-A02B-8263522A1277 Q41176211-039703B8-43C9-452D-88FC-FFF09FAE6929 Q50941572-2B0BCE40-7DD6-4446-9D50-7CEAB18D58E8

P2860

Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study.

http://www.wikidata.org/entity/Q34559981

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.

@ast

Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.

@en

Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.

@nl

type

label

Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.

@ast

Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.

@en

Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.

@nl

prefLabel

Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.

@ast

Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.

@en

Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.

@nl

P1433

Q34559981-E4391970-1BA6-448D-A34A-75706126627B

P1476

Q34559981-3381438C-4782-4C1B-91B4-641D94D06784

P2093

Q34559981-66CF089D-48F0-4E61-9D78-CC8FCEA6EA98

Q34559981-75A500AC-FC30-4BBC-BA8E-7BC402730CEE

Q34559981-80A2B82B-2233-41F0-8C1F-CCC22F34ED5B

Q34559981-C106C5FB-B3FA-405B-8D0F-8C9F24ABEAB4

P2860

Q34559981-03BB07BF-D778-4A08-A5DD-4E17627CBAD5

Q34559981-076B6703-58A4-46DC-97C5-9F4D091EED4F

Q34559981-1FB1082D-247F-42B3-839A-DE7FCD68E6F6

Q34559981-3173B99B-063B-4162-BB8B-57777BB561D5

Q34559981-37A90DB8-1F54-4F08-A560-AE31002A8516

Q34559981-406649A2-7F2A-4B63-832F-C4C18B211568

Q34559981-46F06BD5-6A42-468D-870C-E82B7F075078

Q34559981-4CA9A69F-C11A-406A-999B-ADD697620950

Q34559981-52E5E898-B3E9-4295-924A-B6FBC1A6FB6D

Q34559981-606DE759-4A37-4297-9454-EA06C2E8C005

P2888

Q34559981-101E3A03-B198-4184-B8A0-7A97F6EF64B0

P304

Q34559981-C57FAA48-2971-4781-8D70-AF87920DA1B1

P31

Q34559981-692989E8-7F3C-4135-84E5-0C05A9C3B4C9

P356

Q34559981-EB3E4B03-116E-4B14-A229-15AD0A5FF924

P433

Q34559981-0BA152F2-DC46-45E6-955A-720C6705E858

P478

Q34559981-28643A3F-003E-4BCF-B19F-A21E49888809

P50

Q34559981-EE93F790-CE40-44E9-BED2-E30F2646CBA6

P577

Q34559981-34FF3A9D-E345-4E0D-AE08-C1111646409E

P6179

Q34559981-A586D710-E50A-4463-BB6B-D4AC48966875

P698

Q34559981-35BB5E98-F482-49F9-9C78-67944A7DEBED

P921

Q34559981-1E8E4DBB-5D01-4995-AFD6-04284C97CDB0

Q34559981-90C02E33-3808-4673-927C-9D77DE899404

P932

Q34559981-D25D105E-2A09-466F-87F7-C549EC64E5F5

P356

S00592-014-0663-2

P1433

Acta Diabetologica

P1476

Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.

@en

P2093

Allison B Goldfine

http://www.w3.org/2001/XMLSchema#string

Brendan M Everett

http://www.w3.org/2001/XMLSchema#string

Jun Liu

http://www.w3.org/2001/XMLSchema#string

Robert J Glynn

http://www.w3.org/2001/XMLSchema#string

P2860

Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies

A systematic review of validated methods for identifying heart failure using administrative data

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Standards of medical care in diabetes--2014

An algorithm to identify incident myocardial infarction using Medicaid data.

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.

A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data

Diabetes mellitus and its impact on long-term outcomes after coronary artery bypass graft surgery.

P2888

s00592-014-0663-2

P304

1015-1023

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00592-014-0663-2

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1009834390

http://www.w3.org/2001/XMLSchema#string

P698

25311055

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

type-2 diabetes

P932

4241160

http://www.w3.org/2001/XMLSchema#string